Posts Tagged: "neurodegenerative diseases"

The patent space surrounding marijuana formulations for medical use is still wide open despite the current march towards legalization. According to patent portfolio analysis tools available through Innography, there are a total of 66 U.S. patent grants and 62 U.S. patent applications related to medical marijuana. As the pie chart here will show readers, the top three asset holders in this space are La Jolla, CA-based Auspex Pharmaceuticals (NASDAQ:ASPX), Leidos Holdings (NYSE:LDOS) and the University of Connecticut… In the middle of November, New York City-based biotech firm AXIM Biotechnologies (OTCMKTS:AXIM) announced that it had secured a new patent grant claiming the use of all cannabinoids in controlled-release chewing gum products containing cannabinoids.